Jamie DowlingSide effects wrongly listed as "uncommon" in a Parkison's medication.
The Chair of the Commons Health Select Committee is not happy and wants government action against the UK's drug safety regulator, the MHRA.
NewsletterTFUK Medical Regulator Stops Children’s Puberty Blocker Study Over Safety Concerns
UK medical study on puberty blockers for children paused by MHRA due to safety concerns. Study researchers to meet next week. Who is affected?
#PubertyBlockers, #UKHealth, #MedicalStudy, #ChildSafety, #MHRA
https://newsletter.tf/uk-pauses-childrens-puberty-blocker-study-over-safety-concerns/
The UK's Pathways study on puberty blockers for children has been paused. The regulator MHRA has serious safety worries, especially about the minimum age for participants.
#PubertyBlockers, #UKHealth, #MedicalStudy, #ChildSafety, #MHRA
https://newsletter.tf/uk-pauses-childrens-puberty-blocker-study-over-safety-concerns/
UK Puberty Blocker Trial Paused Amid Regulator's Safety Concerns
UK's Pathways trial for puberty blockers paused by MHRA due to safety concerns. Discusses age limits and future of the trial for young people.
#PubertyBlockers, #UKTrial, #MHRA, #YouthHealth, #GenderIncongruence
https://newsletter.tf/uk-puberty-blocker-trial-paused-due-to-mhra-safety-concerns/
The UK's Pathways trial for puberty blockers has been paused. The regulator, MHRA, has safety concerns, especially about the age limit for participants.
#PubertyBlockers, #UKTrial, #MHRA, #YouthHealth, #GenderIncongruence
https://newsletter.tf/uk-puberty-blocker-trial-paused-due-to-mhra-safety-concerns/
Clinical Trial for Puberty Blockers Paused Amid Regulatory Concerns
A UK clinical trial for puberty blockers for gender incongruence is paused. The MHRA has safety concerns about young participants, especially the minimum age.
#PubertyBlockers, #ClinicalTrial, #MHRA, #ChildSafety, #GenderIncongruence
https://newsletter.tf/uk-puberty-blocker-trial-paused-for-young-people-due-to-safety-worries/
The PATHWAYS trial for puberty blockers in young people is on hold. The MHRA wants to raise the minimum age from 10 to 14 due to safety concerns.
#PubertyBlockers, #ClinicalTrial, #MHRA, #ChildSafety, #GenderIncongruence
https://newsletter.tf/uk-puberty-blocker-trial-paused-for-young-people-due-to-safety-worries/
Mind LudeThe MHRA's 'AI Airlock' is apparently hitting warp speed on AI tools for patient care, aiming to slash agonizing wait times for diagnoses. From clinical note-takers to advanced cancer diagnostics, it's all hands on deck.
Just remember, 'it works on my machine' takes on a whole new meaning when dealing with actual humans. What kind of rigorous testing do you think these medical AIs *really* need?
#AIforHealth #DigitalHealth #MHRA #HealthcareAI #TechNews
https://www.artificialintelligence-news.com/news/mhra-fast-tracks-next-wave-of-ai-tools-for-patient-care/
thesentinelcurrentMHRA issues urgent safety guidance for GLP-1 skinny jab medicines like Ozempic and Mounjaro. Use only under medical supervision to avoid risks. Read more: https://www.thesentinelcurrent.com/health-skinny-jabs-safety-risks/ #GLP1 #SkinnyJabs #MHRA #HealthSafety #WeightLoss
Artinis NIRS